Skip to main content
Equibles

HRT FINANCIAL LP

Position in MYGN — Myriad Genetics Inc

CIK 1475597 NEW YORK, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,097,469
-$4,940,966 QoQ
Shares Held
542,464
-69.6% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 196 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $274,130,834 across 19 Diagnostics & Research names. MYGN ranks #13 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 703,915 $105,608,367
2 NTRA
Natera, Inc.
 125,379 $34,034,129
3 ILMN
Illumina, Inc.
 137,982 $24,261,375
4 IDXX
Idexx Laboratories Inc /De
 37,575 $19,780,983
5 SHC
Sotera Health Co
 1,111,462 $19,728,450
6 MEDP
Medpace Holdings, Inc.
 34,527 $18,285,153
7 PSNL
Personalis, Inc.
 930,816 $12,472,934
8 BLLN
BillionToOne, Inc.
 80,709 $9,683,465

All Filings in MYGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,097,469 542,464
2026-03-31 $8,038,435 1,786,319
2025-12-31 $2,883,538 468,868
2025-09-30 $5,715,813 790,569
2025-06-30 $742,869 139,900
2024-09-30 $607,866 22,193
2023-09-30 $1,130,370 70,472
2023-03-31 $2,399,868 103,309
2022-12-31 $542,572 37,393
2022-03-31 $1,053,687 41,813
2020-12-31 $558,047 28,227
2020-09-30 $508,872 39,024